Abstract
Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of lower motor neurons. We have assayed deletions in two candidate genes, the survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes, in 108 samples, of which 46 were from SMA patients, and 62 were from unaffected subjects. The SMA patients included 3 from Bahrain, 9 from South Africa, 2 from India, 5 from Oman, 1 from Saudi Arabia, and 26 from Kuwait. SMN gene exons 7 and 8 were deleted in all type I SMA patients. NAIP gene exons 5 and 6 were deleted in 22 of 23 type I SMA patients. SMN gene exon 7 was deleted in all type II SMA patients while exon 8 was deleted in 19 of 21 type II patients. In 1 type II SMA patient, both centromeric and telomeric copies of SMN exon 8 were deleted. NAIP gene exons 5 and 6 were deleted in only 1 type II SMA patient. In 1 of the 2 type III SMA patients, SMN gene exons 7 and 8 were deleted with no deletion in the NAIP gene, while in the second patient, deletions were detected in both SMN and NAIP genes. None of the 62 unaffected subjects had deletions in either the SMN or NAIP gene. The incidence of biallelic polymorphism in SMN gene exon 7 (BsmAl) was found to be similar (97%) to that (98%) reported in a Spanish population but was significantly different from that reported from Taiwan (0%). The incidence of a second polymorphism in SMN gene exon 8 (presence of the sequence ATGGCCT) was markedly different in our population (97%) and those reported from Spain (50%) and Taiwan (0%).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Biros I, Forrest S. Spinal muscular atrophy: Untangling the knot? J Med Genet 36:1–8;1999.
Brahe C, Clermont O, Zappata S, Tiziano F, Melki J, Neri G. Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. Hum Mol Genet 5:1971–1976;1996.
Burglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnich A, Pequignot EV, Egly JM, Melki J. The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. Am J Hum Genet 60:72–79;1997.
Bussaglia E, Clermont O, Tizzano E, Lefebvre S, Burglen L, Cruaud C, Urtizberea JA, Colomer J, Munnich A, Baiget M, Melki J. A frameshift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 11:335–337;1995.
Campbell L, Allyson P, Ignatius J, Dubowitz V, Davies K. Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype. Am J Hum Genet 61:40–50;1997.
Chang JG, Jong YJ, Lin SP, Soong B-W, Tsai C-H, Yang T-Y, Chang CP, Wang W-S. Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents. Hum Genet 100:577–581;1997.
Cobben JM, van der Steege G, Grootscholten P, de Visser M, Scheffer H, Buys CHCM. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 57:805–808;1995.
Devriendt K, Lammens M, Schollen E, Van Hole C, Dom R, Devlieger H, Cassiman JJ, et al. Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann Neurol 40:731–738;1996.
DiDonato CJ, Ingraham SE, Mendell JR, Prior TW, Lenard S, Moxley RT, Florence J, Burghes AH. Deletion and conversion in spinal muscular atrophy patients: Is there a relationship to severity? Ann Neurol 41:230–237;1996.
Hahnen E, Schonling J, Rudnik-Schoneborn S, Zerras K, Wirth B. Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: New insights into molecular mechanisms responsible for the disease. Am J Hum Genet 59:1057–1065;1996.
Hahnen E, Forkert R, Marke C, Rudnik-Schoneborn S, Schonling J, Zerras K, Wirth B. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: Evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 4:1927–1933;1995.
Haider MZ, Moosa A. Gene deletions in Arab patients with spinal muscular atrophy. J Child Neurol 12:310–313;1997.
Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Violett L, Benichou B, Cruaud C, Millasseau P, Zeviani M, Le Paslier D, Frezal J, Cohen D, Weissenbach J, Munnich A, Melki J. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155–165;1995.
Munsat TL, Davies KE. Spinal muscular atrophy. In: Emery AEH, ed. Diagnostic Criteria for Neuromuscular Disorders. Baarn, European Neuromuscular Centre, 48–54;1994.
Parsons WD, McAndrew P, Monani U, Mendell J, Burghes A, Prior T. An 11-base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: Further evidence for SMN as the primary SMA-determining gene. Hum Mol Genet 5:1727–1732;1996.
Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167–178;1995.
Roy N, McLean MD, Besner JA, Lefebvre C, Salih M, Carpten JD, Burghes AH, Yaraghi Z, Ikeda JE, Korneluk RG. Refined physical map of the spinal muscular atrophy gene (SMA) region at 5q13 based on YAC and cosmid contiguous arrays. Genomics 26:451–460;1995.
Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 4:631–634;1995.
Sambrook J, Fritsch F, Maniatis T. Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989.
Samilchuk E, D'Souza B, Bastaki L, Awadi S. Deletion analysis of the SMN and NAIP genes in Kuwaiti patients with spinal muscular atrophy. Hum Genet 98:524–527;1996.
Simard LR, Rochette C, Semionov A, Morgan K, Vanasse M. SMNT and NAIP mutations in Canadian families with spinal muscular atrophy (SMA): Genotype/phenotype correlations with disease severity. Am J Med Genet 72:51–58;1997.
Stewart H, Wallace A, McGaughran J, Mountford R, Kingston H. Molecular diagnosis of spinal muscular atrophy. Arch Dis Child 78:531–535;1998.
Taylor JE, Thomas NH, Lewis CM, Abbs SJ, Rodrigues NR, Davies KE, Mathew CG. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet 6:467–474;1998.
van der Steege G, Grootscholten PM, van der Vlies P, Draaijers TG, Osinga J, Cobben JM, Scheffer H, Buys CHCM. PCR-based DNA test to confirm the clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 345:985–986;1995.
van der Steege G, Grootscholten PM, Cobben JM, Zappata S, Scheffer H, den Dunnen JT, van Ommen G-JB, Brahe C, Buys CHCM. Apparent gene conversion involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. Am J Hum Genet 59:834–838;1996.
Velasco E, Valero C, Valero A, Moreno F, Hernandez CC. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet 5:257–263;1996.
Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik-Schoneborn S, Weinker T, Zerres K. Quantitative analysis of survival motor neuron copies: Identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 64:1340–1356;1999.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haider, M.Z., Moosa, A., Dalal, H. et al. Gene deletion patterns in spinal muscular atrophy patients with different clinical phenotypes. J Biomed Sci 8, 191–196 (2001). https://doi.org/10.1007/BF02256412
Issue Date:
DOI: https://doi.org/10.1007/BF02256412